Tag: Diabetes: Type II
Nonalcoholic Steatohepatitis Will Pose Clinical, Economic Burden
Model predicts rising costs for care of U.S. patients with NASH and T2DM over next 20 years
Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes
Gout incidence rate significantly reduced with SGLT2 inhibitor versus GLP-1 receptor agonist
Bariatric Surgery May Aid T2DM-Related Outcomes at Five Years
Benefits seen for diabetes remission, weight loss, changes in metabolic parameters
Treating Oral Disease Could Yield T2DM-Related Cost Savings
Model shows benefits include reductions in tooth loss and diabetes-related microvascular disease
Poor Diet Contributes Substantially to Cardiometabolic Disease Costs
Diet tied to more than $50 billion in annual health care costs for heart disease, stroke, diabetes
Bariatric Surgery in Teens May Cut Diabetic Kidney Disease Risk
Decreased rates of hyperfiltration, elevated UAE seen among surgically treated obese teens with T2DM
Diabetes Prevalence Varies by Race, Ethnicity
Adjusted rates lower for non-Hispanic white versus Hispanic, non-Hispanic black, non-Hispanic Asian groups
Endocrine Society Releases Hypoglycemia Performance Measures
Quality measures help providers identify older adults with T2DM who are at increased risk for hypoglycemia
Age at Obesity Onset Tied to Risk for Type 2 Diabetes in Women
Risk for diabetes decreased for each year increment in age at onset of obesity
HbA1c Minimally Adds to CVD Risk Prediction in Prediabetes
Classical risk factors explain most of the increased risk for CVD associated with HbA1c in prediabetes
